Riskpilot← Back to searchSign inGet full accessMed MOLO Konsult AB
ABIn liquidationOrg 5567757405General medical practice activities · NACE 8621Est. 20091 employees
Revenue 2025
SEK 44K
EBITDA margin
-9.7%
+85% vs 2024
Equity ratio
94.4%
Financial strength
Net profit 2025
SEK 85K
+413% vs 2024
| Revenue | SEK 44K | — |
| EBITDA | SEK -4K | +85% |
| Net profit | SEK 85K | +413% |
| Total assets | SEK 218K | +64% |
| Equity | SEK 206K | +71% |
| Employees | 1 | — |
Legal name
Med MOLO Konsult AB
Org number
5567757405
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
12 januari 2009
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget ska bedriva konsultverksamhet, service- och föredrag samt materialframtagning inom hälsa och sjukvård och därmed förenlig verksamhet.
Address
Phone
+46705195454
Email
eva-britt@ebkforetagssupport.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 261 | 160 | 44 | 0 | 44 |
| Staff expenses | — | −21 | −11 | −2 | −9 |
| EBITDA | 179 | 90 | −6 | −28 | −4 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 179 | 90 | −6 | −28 | −49 |
| Net financials | 6 | −0 | −5 | 1 | 134 |
| Profit before tax | 185 | 90 | −11 | −27 | 85 |
| Tax | −40 | −19 | 5 | — | — |
| Net profit | 145 | 71 | −6 | −27 | 85 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 355 | 278 | 207 | 133 | 218 |
| Equity | 283 | 204 | 148 | 121 | 206 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 72 | 75 | 59 | 12 | 12 |
| Total debt | 72 | 75 | 59 | 12 | 12 |
EBITDA margin
-9.7%
This company
15.8%
Market median
-161% vs market
20212025
Equity ratio
94.4%
This company
38.2%
Market median
+147% vs market
20212025
Return on equity
41.4%
This company
18.4%
Market median
+125% vs market
20212025
Net profit margin
192.3%
This company
8.1%
Market median
+2274% vs market
20212025
Asset turnover
0.20×
This company
1.12×
Market median
-82% vs market
20212025
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EM Liquidator | Liquidator | 2025 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Board of Directors | 2022 – 2025 | |
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Med MOLO Konsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva-Britt M Karlsson Ronnede | Liquidator | 0 companies |
| Anne Inger Margareta Olofsdotter | Board of Directors | 0 companies |
| Lars Anders Andersson | Deputy Board Member | 0 companies |